Ruggero Bettini

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 24

Top Venues

Pharmaceutics

Micromachines

Drug delivery and translational research

Expert opinion on therapeutic patents

University of Parma

University of Pavia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Parma Aug 01 2011

Italy

Professor :: Food and Drug Department

Education History

University of Pavia Jan 01 1991 - Dec 31 1994

Italy

PHD

Publications

Daisy Sorgi, Andrea Sartori, Saveria Germani, Rosita Nicolella Gentile, Annalisa Bianchera, Ruggero Bettini
Imiquimod Solubility in Different Solvents: An Interpretative Approach. Pharmaceutics 16 (2) (2024)
Annalisa Bianchera, Gaetano Donofrio, Fabio Sonvico, Ruggero Bettini
Dry powder formulations of hyperimmune serum. Drug delivery and translational research (2024)
Daisy Sorgi, Andrea Sartori, Saveria Germani, Rosita Nicolella Gentile, Annalisa Bianchera, Ruggero Bettini
Imiquimod Solubility in Different Solvents: An Interpretative Approach. Pharmaceutics 16 (2) (2024)
Carlo Bergonzi, Annalisa Bianchera, Giulia Remaggi, Maria Cristina Ossiprandi, Ruggero Bettini, Lisa Elviri
3D Printed Chitosan/Alginate Hydrogels for the Controlled Release of Silver Sulfadiazine in Wound Healing Applications: Design, Characterization and Antimicrobial Activity. Micromachines 14 (1) (2023)
Davide D'Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics 15 (3) (2023)
Davide D'Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics 15 (3) (2023)
Annalisa Bianchera, Viviana Vilardo, Roberta Giaccari, Annalisa Michielon, Gianluca Bazzoli, Francesca Buttini, Marina Aiello, Alfredo Chetta, Stefano Bruno, Ruggero Bettini
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin. Drug delivery and translational research (2023)
Carlo Bergonzi, Annalisa Bianchera, Giulia Remaggi, Maria Cristina Ossiprandi, Ruggero Bettini, Lisa Elviri
3D Printed Chitosan/Alginate Hydrogels for the Controlled Release of Silver Sulfadiazine in Wound Healing Applications: Design, Characterization and Antimicrobial Activity. Micromachines 14 (1) (2023)
Carlo Bergonzi, Annalisa Bianchera, Giulia Remaggi, Maria Cristina Ossiprandi, Ruggero Bettini, Lisa Elviri
3D Printed Chitosan/Alginate Hydrogels for the Controlled Release of Silver Sulfadiazine in Wound Healing Applications: Design, Characterization and Antimicrobial Activity. Micromachines 14 (1) (2023)
Davide D'Angelo, Eride Quarta, Stefania Glieca, Giada Varacca, Lisa Flammini, Simona Bertoni, Martina Brandolini, Vittorio Sambri, Laura Grumiro, Giulia Gatti, Giorgio Dirani, Francesca Taddei, Annalisa Bianchera, Fabio Sonvico, Ruggero Bettini, Francesca Buttini
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. Pharmaceutics 15 (3) (2023)
Carlo Bergonzi, Annalisa Bianchera, Giulia Remaggi, Maria Cristina Ossiprandi, Ruggero Bettini, Lisa Elviri
3D Printed Chitosan/Alginate Hydrogels for the Controlled Release of Silver Sulfadiazine in Wound Healing Applications: Design, Characterization and Antimicrobial Activity. Micromachines 14 (1) (2023)
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, Gianluca Bazzoli, Nicoletta Ronda, Giovanni Pighini, Ilaria Zanotti, Carmine Giorgio, Andrea Mozzarelli, Ruggero Bettini, Stefano Bruno
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept. Pharmaceutics 14 (12) (2022)
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, Gianluca Bazzoli, Nicoletta Ronda, Giovanni Pighini, Ilaria Zanotti, Carmine Giorgio, Andrea Mozzarelli, Ruggero Bettini, Stefano Bruno
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept. Pharmaceutics 14 (12) (2022)
Annalisa Bianchera, Marino Nebuloni, Nicola Colombo, Davide Pirola, Ruggero Bettini
Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin. Pharmaceutics 15 (1) (2022)
Annalisa Bianchera, Marino Nebuloni, Nicola Colombo, Davide Pirola, Ruggero Bettini
Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin. Pharmaceutics 15 (1) (2022)
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, Gianluca Bazzoli, Nicoletta Ronda, Giovanni Pighini, Ilaria Zanotti, Carmine Giorgio, Andrea Mozzarelli, Ruggero Bettini, Stefano Bruno
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept. Pharmaceutics 14 (12) (2022)
Annalisa Bianchera, Esraa'a Alomari, Annalisa Michielon, Gianluca Bazzoli, Nicoletta Ronda, Giovanni Pighini, Ilaria Zanotti, Carmine Giorgio, Andrea Mozzarelli, Ruggero Bettini, Stefano Bruno
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept. Pharmaceutics 14 (12) (2022)
Annalisa Bianchera, Marino Nebuloni, Nicola Colombo, Davide Pirola, Ruggero Bettini
Highly Polymorphic Materials and Dissolution Behaviour: The Peculiar Case of Rifaximin. Pharmaceutics 15 (1) (2022)
Ayca Altay Benetti, Annalisa Bianchera, Francesca Buttini, Laura Bertocchi, Ruggero Bettini
Mannitol Polymorphs as Carrier in DPIs Formulations: Isolation Characterization and Performance. Pharmaceutics 13 (8) (2021)
Candelaria Ines Camara, Laura Bertocchi, Caterina Ricci, Rosaria Bassi, Annalisa Bianchera, Laura Cantu', Ruggero Bettini, Elena Del Favero
Hyaluronic Acid-Dexamethasone Nanoparticles for Local Adjunct Therapy of Lung Inflammation. International journal of molecular sciences 22 (19) (2021)
Eride Quarta, Fabio Sonvico, Ruggero Bettini, Claudio De Luca, Alessandro Dotti, Daniele Catalucci, Michele Iafisco, Lorenzo Degli Esposti, Gaia Colombo, Giovanna Trevisi, Dimitrios M Rekkas, Alessandra Rossi, Tin Wui Wong, Francesca Buttini, Paolo Colombo
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design. Pharmaceutics 13 (11) (2021)
Annalisa Bianchera, Francesca Buttini, Ruggero Bettini
Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents. Expert opinion on therapeutic patents 30 (12) (2020)
Andrea Della Bella, Michele Müller, Andrea Danani, Luciano Soldati, Ruggero Bettini
Effect of Lactose Pseudopolymorphic Transition on the Aerosolization Performance of Drug/Carrier Mixtures. Pharmaceutics 11 (11) (2019)
Irene Rossi, Francesca Buttini, Fabio Sonvico, Filippo Affaticati, Francesco Martinelli, Giannamaria Annunziato, Diana Machado, Miguel Viveiros, Marco Pieroni, Ruggero Bettini
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections. Pharmaceutics 11 (5) (2019)
Ruggero Bettini, Maria Cristina Bonferoni, Paolo Colombo, Laura Zanelotti, Carla Caramella
Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes. BioMed research international 2014 (2014)

Ruggero Bettini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ruggero Bettini